Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kath Kerry

- PMLiVE

A new era of smart pharma

How smarter pharmaceuticals and pharmacovigilance are transforming healthcare

Celgene building

Celgene boosts CAR-T stake again with Bluebird Bio deal

The US biotech could receive $70m in development milestones for the candidate

Sanofi reception

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

Dupixent is still too expensive despite discount, says the UK’s cost effectiveness body

- PMLiVE

Ipsen bolsters leadership team

Ivana Magovcevic-Liebisch and Régis Mulot join the biopharma

- PMLiVE

Lucid’s first class of 2018 graduates from Lucid’s Futures Academy

Four graduates complete an eight-week training course

- PMLiVE

Health insurers will test blockchain for data handling

Aims to make health records more accurate and reliable

- PMLiVE

The Patient Safety Challenge

Understanding the causes of medication  errors and how to reduce them

- PMLiVE

Commercial innovation in biotech organisations

Blue Latitude Health speaks to Salma Jutt Vice President of US Marketing and Head of Commercial Innovation at a biotech specialising in treating weight loss and obesity.

Blue Latitude Health

- PMLiVE

Life science companies can’t keep up with technology competitors

The industry must look beyond novel drugs and devices, warns report

- PMLiVE

Cognite strengthens team with two new additions

Storm Beadle and Ines Mastrolia join the agency

- PMLiVE

Nabriva Therapeutics appoints chief medical officer

Jennifer Schranz will lead the company’s clinical development business

Sanofi reception

Sanofi’s PD-1 inhibitor starts EU review for skin cancer

Cemiplimab could be the first PD-1-targeting drug approved for CSCC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links